Search research articles
Contact Us
Filters
Showing results (91-100 of 162) with videos related to
Page
of 17
Sort By:
Oncotarget
|
November 18, 2015
INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas
Meng Na Chi, Su Tang Guo, James S Wilmott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2021
G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
Gregory M Kelly, Fares Al-Ejeh, Robert McCuaig, et al.
Nature Communications
|
April 8, 2024
Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma
Xinyu Bai, Grace H Attrill, Tuba N Gide, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2017
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors
Hojabr Kakavand, Robert V Rawson, Gulietta M Pupo, et al.
JCO Precision Oncology
|
March 12, 2026
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study
Andrea Boutros, Matteo S Carlino, Raja Chaganti, et al.
Genome Medicine
|
May 26, 2026
Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes
Eva R Shteinman, Grace H Attrill, Nigel G Maher, et al.
Oncotarget
|
October 22, 2014
TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells
Selina K Sutton, Jessica Koach, Owen Tan, et al.
The Journal of Investigative Dermatology
|
August 31, 2012
BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma
Graham J Mann, Gulietta M Pupo, Anna E Campain, et al.
Ebiomedicine
|
July 10, 2022
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms
Thazin Nwe Aung, Saba Shafi, James S Wilmott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2018
CD103<sup>+</sup> Tumor-Resident CD8<sup>+</sup> T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment
Jarem Edwards, James S Wilmott, Jason Madore, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 162) with videos related to
Sort By:
Page
of 17
Oncotarget
|
November 18, 2015
INPP4B is upregulated and functions as an oncogenic driver through SGK3 in a subset of melanomas
Meng Na Chi, Su Tang Guo, James S Wilmott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 16, 2021
G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma
Gregory M Kelly, Fares Al-Ejeh, Robert McCuaig, et al.
Nature Communications
|
April 8, 2024
Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma
Xinyu Bai, Grace H Attrill, Tuba N Gide, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2017
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors
Hojabr Kakavand, Robert V Rawson, Gulietta M Pupo, et al.
JCO Precision Oncology
|
March 12, 2026
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study
Andrea Boutros, Matteo S Carlino, Raja Chaganti, et al.
Genome Medicine
|
May 26, 2026
Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes
Eva R Shteinman, Grace H Attrill, Nigel G Maher, et al.
Oncotarget
|
October 22, 2014
TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells
Selina K Sutton, Jessica Koach, Owen Tan, et al.
The Journal of Investigative Dermatology
|
August 31, 2012
BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma
Graham J Mann, Gulietta M Pupo, Anna E Campain, et al.
Ebiomedicine
|
July 10, 2022
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms
Thazin Nwe Aung, Saba Shafi, James S Wilmott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2018
CD103<sup>+</sup> Tumor-Resident CD8<sup>+</sup> T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment
Jarem Edwards, James S Wilmott, Jason Madore, et al.
Page
of 17